Rodin Therapeutics seals $27 mln

Cambridge, Massachusetts-based Rodin Therapeutics, a biotech company, has closed $27 million in financing. The investors included Atlas Venture, GV, Hatteras Venture Partners, Remeditex Ventures and Third Point Ventures.

North AmericaUSBriefs